18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy

BACKGROUND: Prostate cancer is highly prevalent worldwide. Androgen deprivation therapy (ADT) remains the treatment of choice for incurable prostate cancer, but majority of patients develop disease recurrence following ADT. There is therefore an urgent need for early detection of treatment resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Malviya, Gaurav, Patel, Rachana, Salji, Mark, Martinez, Rafael S., Repiscak, Peter, Mui, Ernest, Champion, Susan, Mrowinska, Agata, Johnson, Emma, AlRasheedi, Maha, Pimlott, Sally, Lewis, David, Leung, Hing Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688773/
https://www.ncbi.nlm.nih.gov/pubmed/33237350
http://dx.doi.org/10.1186/s13550-020-00728-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688773/
https://www.ncbi.nlm.nih.gov/pubmed/33237350
http://dx.doi.org/10.1186/s13550-020-00728-9

Ejemplares similares